Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in PCD pharma franchise in Hyderabad

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in pharmaceutical manufacturing company in Mumbai

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in hypertension pharma franchise in Pune

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in pharma suppliers in Delhi

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in pharma export companies in Kolkata
Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 12.5mg Tablet in pharma franchise opportunities in Bengaluru

Telbolife Trio 12.5 Tablet

Composition : Telmisartan 40 mg + Cilnidipine 10 mg + Metoprolol 12.5 mg

Dosage Form : Tablet

Packaging Type : Alu ALu

Packaging : 10x15

Price : ₹283/-

Please Contact For Best Price

Telbolife Trio 12.5 Tablet is a fixed-dose combination of three antihypertensive agents designed to provide comprehensive control of high blood pressure.

  • Telmisartan is an angiotensin II receptor blocker (ARB) that prevents blood vessel constriction, improving blood flow.

  • Cilnidipine is a dual L/N-type calcium channel blocker that reduces vascular resistance and also modulates sympathetic nerve activity.

  • Metoprolol is a beta-blocker that slows down the heart rate and reduces cardiac output, offering cardioprotective benefits.

Together, these agents act synergistically to manage blood pressure effectively, reduce cardiovascular risks, and improve long-term outcomes in hypertensive patients, especially those with coexisting cardiac conditions.

Read More

About the Product

Telbolife Trio 12.5 Tablet is a fixed-dose combination of three antihypertensive agents designed to provide comprehensive control of high blood pressure.

  • Telmisartan is an angiotensin II receptor blocker (ARB) that prevents blood vessel constriction, improving blood flow.

  • Cilnidipine is a dual L/N-type calcium channel blocker that reduces vascular resistance and also modulates sympathetic nerve activity.

  • Metoprolol is a beta-blocker that slows down the heart rate and reduces cardiac output, offering cardioprotective benefits.

Together, these agents act synergistically to manage blood pressure effectively, reduce cardiovascular risks, and improve long-term outcomes in hypertensive patients, especially those with coexisting cardiac conditions.

Patients may experience dizziness, fatigue, bradycardia, flushing, or swelling of the feet. In rare cases, hypotension, electrolyte imbalance, or gastrointestinal discomfort may occur. Regular monitoring is recommended.

Telbolife Trio 12.5 Tablet is indicated for the treatment of essential hypertension, particularly in patients requiring multi-drug therapy for optimal control. It is also beneficial in patients with cardiac comorbidities such as angina, left ventricular hypertrophy, or mild heart failure, providing vascular protection and enhanced compliance through once-daily dosing.

Use only under medical supervision. Not recommended during pregnancy or breastfeeding. Patients with renal or hepatic impairment, conduction abnormalities, or bronchial asthma should be monitored closely. Avoid abrupt discontinuation.

Store below 25°C in a dry, cool place. Protect from direct light and moisture. Keep out of reach of children.

Get in Touch